Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pertussis Vaccine | 4 | 2017 | 89 | 2.08 | Why? |
| Whooping Cough | 6 | 2017 | 201 | 2.04 | Why? |
| Immunity, Maternally-Acquired | 2 | 2017 | 179 | 1.19 | Why? |
| Tetanus | 1 | 2017 | 61 | 0.67 | Why? |
| Diphtheria | 1 | 2017 | 74 | 0.66 | Why? |
| Antibodies, Bacterial | 1 | 2017 | 510 | 0.50 | Why? |
| Infant, Premature | 1 | 2017 | 883 | 0.46 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 907 | 0.45 | Why? |
| Immunization Schedule | 1 | 2017 | 1305 | 0.40 | Why? |
| Immunization | 2 | 2019 | 2019 | 0.38 | Why? |
| Liver Transplantation | 2 | 2021 | 2864 | 0.36 | Why? |
| Transplant Recipients | 2 | 2021 | 4982 | 0.35 | Why? |
| Vaccination | 9 | 2021 | 19050 | 0.35 | Why? |
| Immunogenicity, Vaccine | 2 | 2021 | 4624 | 0.31 | Why? |
| Germinal Center | 2 | 2019 | 332 | 0.30 | Why? |
| Influenza Vaccines | 2 | 2017 | 2941 | 0.27 | Why? |
| B-Lymphocytes | 4 | 2019 | 4418 | 0.26 | Why? |
| Apolipoprotein A-I | 1 | 2021 | 148 | 0.21 | Why? |
| Encephalitis, Varicella Zoster | 1 | 2019 | 9 | 0.21 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.20 | Why? |
| Biliary Tract Neoplasms | 1 | 2021 | 93 | 0.20 | Why? |
| Maternal-Fetal Exchange | 2 | 2019 | 209 | 0.20 | Why? |
| Glycolipids | 1 | 2018 | 19 | 0.18 | Why? |
| Adaptive Immunity | 2 | 2020 | 2585 | 0.18 | Why? |
| Infectious Disease Medicine | 1 | 2021 | 311 | 0.17 | Why? |
| Herpesvirus 3, Human | 1 | 2019 | 228 | 0.16 | Why? |
| Bordetella pertussis | 1 | 2017 | 117 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| Infant | 5 | 2020 | 30274 | 0.15 | Why? |
| beta-Glucans | 1 | 2018 | 176 | 0.15 | Why? |
| Pregnancy Trimester, Second | 1 | 2017 | 314 | 0.15 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2019 | 497 | 0.15 | Why? |
| Mucous Membrane | 1 | 2017 | 305 | 0.15 | Why? |
| Pregnancy Trimester, Third | 1 | 2017 | 445 | 0.15 | Why? |
| Vaccines, DNA | 1 | 2020 | 871 | 0.13 | Why? |
| Pregnancy | 6 | 2019 | 23879 | 0.13 | Why? |
| Orthomyxoviridae Infections | 2 | 2019 | 1001 | 0.13 | Why? |
| Infant, Newborn | 5 | 2017 | 23105 | 0.13 | Why? |
| Infant, Newborn, Diseases | 1 | 2017 | 394 | 0.13 | Why? |
| Antibodies | 1 | 2019 | 846 | 0.12 | Why? |
| Immunomodulation | 1 | 2021 | 1472 | 0.12 | Why? |
| Postpartum Period | 1 | 2017 | 936 | 0.11 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.11 | Why? |
| Orthomyxoviridae | 1 | 2019 | 1168 | 0.11 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.10 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.10 | Why? |
| Switzerland | 1 | 2017 | 2738 | 0.10 | Why? |
| Child | 5 | 2021 | 70012 | 0.09 | Why? |
| Adjuvants, Immunologic | 1 | 2018 | 1709 | 0.09 | Why? |
| Immunization Programs | 1 | 2021 | 2006 | 0.09 | Why? |
| Animals, Newborn | 2 | 2019 | 350 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2020 | 3231 | 0.09 | Why? |
| Immunocompromised Host | 2 | 2021 | 5150 | 0.09 | Why? |
| Humans | 20 | 2021 | 930598 | 0.09 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 2426 | 0.08 | Why? |
| Clinical Decision-Making | 1 | 2021 | 3755 | 0.08 | Why? |
| Prenatal Care | 1 | 2017 | 1314 | 0.08 | Why? |
| Virus Shedding | 2 | 2020 | 5834 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Influenza, Human | 4 | 2021 | 10779 | 0.08 | Why? |
| Organ Transplantation | 1 | 2021 | 2616 | 0.08 | Why? |
| Antibody Formation | 1 | 2019 | 4038 | 0.07 | Why? |
| Immunologic Memory | 1 | 2017 | 3362 | 0.07 | Why? |
| Liver Diseases | 1 | 2021 | 2698 | 0.07 | Why? |
| Child, Preschool | 2 | 2020 | 36283 | 0.07 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.07 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2018 | 2984 | 0.06 | Why? |
| Disease Management | 1 | 2021 | 6841 | 0.06 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.06 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.06 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2019 | 5837 | 0.06 | Why? |
| Antibodies, Viral | 5 | 2021 | 51949 | 0.06 | Why? |
| Pregnancy Complications, Infectious | 2 | 2017 | 11559 | 0.05 | Why? |
| Toll-Like Receptor 2 | 1 | 2021 | 198 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Sequence Homology, Amino Acid | 1 | 2021 | 945 | 0.05 | Why? |
| Female | 9 | 2021 | 380317 | 0.05 | Why? |
| Toll-Like Receptor 9 | 1 | 2018 | 72 | 0.04 | Why? |
| Mice, Inbred BALB C | 2 | 2019 | 5814 | 0.04 | Why? |
| Mice, Inbred C57BL | 2 | 2019 | 5542 | 0.04 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.04 | Why? |
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2017 | 91 | 0.04 | Why? |
| Risk Adjustment | 1 | 2021 | 730 | 0.04 | Why? |
| Adult | 5 | 2021 | 244371 | 0.04 | Why? |
| Liposomes | 1 | 2018 | 334 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Lectins, C-Type | 1 | 2018 | 405 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
| Toll-Like Receptor 4 | 1 | 2018 | 390 | 0.03 | Why? |
| Animals | 3 | 2019 | 78931 | 0.03 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2018 | 511 | 0.03 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.03 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.03 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.03 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Peptide Fragments | 1 | 2021 | 2075 | 0.03 | Why? |
| Peptides | 1 | 2021 | 2513 | 0.02 | Why? |
| Mice | 2 | 2019 | 21357 | 0.02 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.02 | Why? |
| Membrane Proteins | 1 | 2018 | 1733 | 0.02 | Why? |
| Computational Biology | 1 | 2021 | 4514 | 0.02 | Why? |
| Communicable Diseases | 1 | 2021 | 2148 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Vitamin D | 1 | 2021 | 2904 | 0.02 | Why? |
| Tuberculosis | 1 | 2021 | 2895 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.02 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2021 | 10083 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Male | 2 | 2021 | 367725 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |
| Retrospective Studies | 1 | 2017 | 105322 | 0.00 | Why? |
Eberhardt's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(123)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(82)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_